ALLMedicine™ Hirsutism Center
Research & Reviews 883 results
https://doi.org/10.1186/s13048-023-01134-0
Journal of Ovarian Research; Kitajima M, Kajimura I et. al.
Mar 17th, 2023 - Androgen-producing granulosa cell tumor in adolescent girl is rare condition and clinical characteristics are not fully elucidated. Seventeen years old girl complained of secondary amenorrhea was referred to our out-patient consultation. Markedly ...
https://www.mdedge.com/dermatology/article/261841/acne/spironolactone-inexpensive-effective-option-acne-women
Doug Brunk
Mar 16th, 2023 - HONOLULU – In the clinical experience of Julie C. Harper, MD, an increasing number of women with acne are turning to off-label, long-term treatment with spironolactone.
https://www.ncbi.nlm.nih.gov/pubmed/36920819
American Family Physician; Williams T, Moore JB et. al.
Mar 16th, 2023 - Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of childbearing age. Its complex pathophysiology includes genetic and environmental factors that contribute to insulin resistance in patients with this disease. The...
https://doi.org/10.1007/s00431-023-04875-8
European Journal of Pediatrics; Saei Ghare Naz M, Ozgoli G et. al.
Mar 14th, 2023 - Several health-related quality of life (HRQOL) questionnaires for adults with polycystic ovary syndrome (PCOS) have been developed so far. However, an adolescent-specific HRQOL questionnaire for PCOS patients is still lacking. Hence, this study ai...
https://doi.org/10.1016/j.yebeh.2023.109149
Epilepsy & Behavior : E&B; Alessi N, Coleman H et. al.
Mar 9th, 2023 - People with epilepsy have long reported reduced quality of life (QoL) compared to healthy peers. This initial study seeks to broaden our understanding of QoL in adults with epilepsy, by examining the adverse impact of body image dissatisfaction fo...
Guidelines 3 results
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.
Mar 10th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.
Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...
https://doi.org/10.1210/jc.2007-2437
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Chang RJ et. al.
Feb 7th, 2008 - Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society...
Drugs 52 results see all →
Clinicaltrials.gov 113 results
https://clinicaltrials.gov/ct2/show/NCT05755880
Mar 6th, 2023 - Long-term corticosteroids prescribing was associated with many adverse effects, as increased skin pigmentation, lowering immunity (catching opportunistic infections like herpes zoster, candida and cutaneous abscesses or even flaring localized infe...
https://clinicaltrials.gov/ct2/show/NCT03905941
Mar 2nd, 2023 - This is a randomized, controlled, double-blinded, crossover study. The investigators will recruit women with PCOS in ages 40-49 yo. Subjects will be randomized to either receive metformin (2000 mg daily) or low dose oral contraceptives (OCs: 20 mc...
https://clinicaltrials.gov/ct2/show/NCT05734287
Feb 17th, 2023 - Irregular menstrual cycles are defined as: normal in the first year post menarche as part of the pubertal transition > 1 to < 3 years post menarche: < 21 or > 45 days > 3 years post menarche to perimenopause: < 21 or > 35 days or < 8 cycles per ye...>>
https://clinicaltrials.gov/ct2/show/NCT04979377
Feb 16th, 2023 - Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with an estimated prevalence of 6-15% of the general population worldwide. This heterogeneous syndrome has significant cardio-metabolic, reproduct...
https://clinicaltrials.gov/ct2/show/NCT03135301
Jan 31st, 2023 - Polycystic ovary syndrome accounts for the vast majority of anovulatory symptoms and hyperandrogenism in women. The diagnosis of Polycystic ovary syndrome has life-long implications, with increased risk for infertility, metabolic syndrome, and typ...
News 158 results
https://www.mdedge.com/dermatology/article/261841/acne/spironolactone-inexpensive-effective-option-acne-women
Doug Brunk
Mar 16th, 2023 - HONOLULU – In the clinical experience of Julie C. Harper, MD, an increasing number of women with acne are turning to off-label, long-term treatment with spironolactone.
https://www.mdedge.com/obgyn/article/260094/gynecology/simplify-your-approach-diagnosis-and-treatment-pcos
Robert L. Barbieri, MD
Dec 13th, 2022 - PCOS is a common problem, with a prevalence of 6% to 10% among women of reproductive age. 1 Patients with PCOS often present with hirsutism, acne, female androgenetic alopecia, oligomenorrhea (also known as infrequent menstrual bleeding), amenorrhe.
https://www.medscape.com/viewarticle/982405
Oct 13th, 2022 - Geographic location within the United States appears to have an impact on the specific symptoms of polycystic ovary syndrome (PCOS) that any one particular woman will develop, according to a new prospective cohort study. Women in California were m...
https://www.mdedge.com/dermatology/article/257514/acne/hormonal-therapy-safe-long-term-option-older-women-recalcitrant-acne
Doug Brunk
Aug 31st, 2022 - PORTLAND, ORE. – During her dermatology residency training at the University of California, Irvine, Medical Center, Jenny Murase, MD, remembers hearing a colleague say that her most angry patients of the day were adult women with recalcitrant acne.
https://www.mdedge.com/obgyn/article/255294/gynecology/pcos-comes-high-morbidity-medication-use-late-40s
Marcia Frellick
Jun 8th, 2022 - Women with polycystic ovary syndrome (PCOS) have an increased risk for several diseases and symptoms, many independent of body mass index (BMI), new research indicates. Some diseases are linked for the first time to PCOS in this study, the authors.